An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.

Name: An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study.
Author: Ahmed, Fayyaz

An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study. — المؤلف: Ahmed, Fayyaz — The journal of headache and pain 20190517

المؤلف: Ahmed, Fayyaz
النشر: The journal of headache and pain 20190517
الوصف: 26 p.
الموضوعات: Acetylcholine Release Inhibitors؛ Adult؛ Botulinum Toxins, Type A؛ Chronic Disease؛ Female؛ Humans؛ Male؛ Middle Aged